An analysis of the burden of liver cirrhosis: Differences between the global, China, the United States and India

被引:1
作者
Lu, Keqiang [1 ]
Sui, Juanjuan [2 ]
Yu, Wenhui [3 ]
Chen, Yan [4 ]
Hou, Zhiyong [5 ]
Li, Pengyan [2 ]
Sun, Yuli [6 ]
机构
[1] Shanghai Univ Tradit Chinese Med, Shuguang Hosp, Inst Liver Dis, Shanghai, Peoples R China
[2] Dongying Hosp Shandong Prov Hosp Grp, Dongying Peoples Hosp, Dept Infect Dis, Dongying, Shandong, Peoples R China
[3] Nanjing Univ Chinese Med, Sch Nursing, Nanjing, Peoples R China
[4] Nanjing Univ Chinese Med, Nanjing Drum Tower Hosp, Clin Coll, Dept Nursing, Nanjing, Peoples R China
[5] China Acad Chinese Med Sci, Inst Basic Res Clin Med, Beijing, Peoples R China
[6] Shandong Univ Tradit Chinese Med, Dept Hepatobiliary Internal Med, Affiliated Hosp, Jinan 250000, Shandong, Peoples R China
关键词
cirrhosis; DALYs; deaths; the burden of disease; HEPATITIS-C; CARE; COMPLICATIONS; EPIDEMIOLOGY; PREVALENCE; DISEASE;
D O I
10.1111/liv.16087
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background: Cirrhosis continues to be the most common cause of chronic liver disease- related deaths globally, which puts significant strain on global health. This report aims to investigate the patterns of cirrhosis in China, the United States, India and worldwide from 1990 to 2019 through an epidemiological analysis of the disease utilizing data from the Global Burden of Disease Study (GBD) 2019 database.Methods: Download the GBD database's statistics on liver cirrhosis deaths and Disability-Adjusted Life Years for the years 1990-2019 worldwide as well as for China, the United States and India. Utilize techniques like age-period-cohort interac-tion, decomposition analysis, study of health inequities, Joinpoint model and Bayesian Average Annual Percentage Change model to process the data.Results: The main age group affected by cirrhosis disease, according to the results, is 50-69 years old. According to the Joinpoint model, there has been a negative world-wide Average Annual Percent Change (AAPC) in the burden of cirrhosis between 1990 and 2019. Only the USA's AAPC is positive out of the three nations that were evalu-ated (albeit its 95% confidence interval spans 0). These are China, India and the United States. Forecasting models indicate that the prevalence of cirrhosis will keep rising in the absence of government action. According to decomposition analysis, the main factors contributing to the rising burden of cirrhosis are population ageing and size, whereas changes in the disease's epidemiology slow the disease's growth. Research on health disparities indicates that, between 1990 and 2019, there was a downward trend in health disparities between various locations. Conclusion: Health organizations across different areas should take aggressive meas-ures to address the worrisome prevalence of cirrhosis
引用
收藏
页码:3183 / 3203
页数:21
相关论文
共 55 条
[1]   Survey of alcohol-related cirrhosis at a tertiary care center in North East India [J].
Bhattacharyya M. ;
Barman N.N. ;
Goswami B. .
Indian Journal of Gastroenterology, 2016, 35 (3) :167-172
[2]   COVID-19: Has the Liver Been Spared? [J].
Brandi, Nicolo ;
Spinelli, Daniele ;
Granito, Alessandro ;
Tovoli, Francesco ;
Piscaglia, Fabio ;
Golfieri, Rita ;
Renzulli, Matteo .
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (02)
[3]   Incidence of Hepatocellular Carcinoma in Patients With HCV-Associated Cirrhosis Treated With Direct-Acting Antiviral Agents [J].
Calvaruso, Vincenza ;
Cabibbo, Giuseppe ;
Cacciola, Irene ;
Petta, Salvatore ;
Madonia, Salvatore ;
Bellia, Alessandro ;
Tine, Fabio ;
Distefano, Marco ;
Licata, Anna ;
Giannitrapani, Lydia ;
Prestileo, Tullio ;
Mazzola, Giovanni ;
Di Rosolini, Maria Antonietta ;
Larocca, Licia ;
Bertino, Gaetano ;
Digiacomo, Antonio ;
Benanti, Francesco ;
Guarneri, Luigi ;
Averna, Alfonso ;
Iacobello, Carmelo ;
Magro, Antonio ;
Scalisi, Ignazio ;
Cartabellotta, Fabio ;
Savalli, Francesca ;
Barbara, Marco ;
Davi, Antonio ;
Russello, Maurizio ;
Scifo, Gaetano ;
Squadrito, Giovanni ;
Camma, Calogero ;
Raimondo, Giovanni ;
Craxi, Antonio ;
Di Marco, Vito .
GASTROENTEROLOGY, 2018, 155 (02) :411-+
[4]   Clinical outcomes in patients with chronic hepatitis C after direct-acting antiviral treatment: a prospective cohort study [J].
Carrat, Fabrice ;
Fontaine, Helene ;
Dorival, Celine ;
Simony, Melanie ;
Diallo, Alpha ;
Hezode, Christophe ;
De Ledinghen, Victor ;
Larrey, Dominique ;
Haour, Georges ;
Bronowicki, Jean-Pierre ;
Zoulim, Fabien ;
Asselah, Tarik ;
Marcellin, Patrick ;
Thabut, Dominique ;
Leroy, Vincent ;
Tran, Albert ;
Habersetzer, Francois ;
Samuel, Didier ;
Guyader, Dominique ;
Chazouilleres, Olivier ;
Mathurin, Philippe ;
Metivier, Sophie ;
Alric, Laurent ;
Riachi, Ghassan ;
Gournay, Jerome ;
Abergel, Armand ;
Cales, Paul ;
Ganne, Nathalie ;
Loustaud-Ratti, Veronique ;
D'Alteroche, Louis ;
Causse, Xavier ;
Geist, Claire ;
Minello, Anne ;
Rosa, Isabelle ;
Gelu-Simeon, Moana ;
Portal, Isabelle ;
Raffi, Francois ;
Bourliere, Marc ;
Pol, Stanislas ;
Bonnet, Delphine ;
Payssan-Sicart, Virginie ;
Pomes, Chloe ;
Bailly, Francois ;
Beaudoin, Marjolaine ;
Giboz, Dominique ;
Hartig-Lavie, Kerstin ;
Maynard, Marianne ;
Billaud, Eric ;
Boutoille, David ;
Cavellec, Morane .
LANCET, 2019, 393 (10179) :1453-1464
[5]   Accelerating the elimination of viral hepatitis: a Lancet Gastroenterology & Hepatology Commission [J].
Cooke, Graham S. ;
Andrieux-Meyer, Isabelle ;
Applegate, Tanya L. ;
Atun, Rifat ;
Burry, Jessica R. ;
Cheinquer, Hugo ;
Dusheiko, Geoff ;
Feld, Jordan J. ;
Gore, Charles ;
Griswold, Max G. ;
Hamid, Saeed ;
Hellard, Margaret E. ;
Hou, JinLin ;
Howell, Jess ;
Jia, Jidong ;
Kravchenko, Natalia ;
Lazarus, Jeffrey V. ;
Lemoine, Maud ;
Lesi, Olufunmilayo A. ;
Maistat, Liudmyla ;
McMahon, Brian J. ;
Razavi, Homie ;
Roberts, Teri R. ;
Simmons, Bryony ;
Sonderup, Mark W. ;
Spearman, C. Wendy ;
Taylor, Bridie E. ;
Thomas, David L. ;
Waked, Imam ;
Ward, John W. ;
Wiktor, Stefan Z. ;
Abdo, Ayman ;
Aggarwal, Rakesh ;
Aghemo, Alessio ;
Al-Judaibi, Bandar ;
Al Mahtab, Mamun ;
Altaf, Arshad ;
Ameen, Zyaad ;
Asselah, Tarik ;
Baatarkkhuu, Oidov ;
Barber, Ella ;
Barnes, Eleanor ;
Boulet, Pascale ;
Burrows, Louise ;
Butsashvili, Maia ;
Chan, Erica ;
Chow, Chelsea ;
Cowie, Ben ;
Cunningham, Chris ;
de Araujo, Alexandre .
LANCET GASTROENTEROLOGY & HEPATOLOGY, 2019, 4 (02) :135-184
[6]  
Duan Shu-hong, 2016, Zhongguo Zhong Xi Yi Jie He Za Zhi, V36, P535
[7]   COVID-19 and liver disease [J].
Dufour, Jean-Francois ;
Marjot, Thomas ;
Becchetti, Chiara ;
Tilg, Herbert .
GUT, 2022, 71 (11) :2350-2362
[8]   Alcohol consumption in India- An epidemiological review [J].
Eashwar, V. M. Anantha ;
Umadevi, R. ;
Gopalakrishnan, S. .
JOURNAL OF FAMILY MEDICINE AND PRIMARY CARE, 2020, 9 (01) :49-55
[9]   Modeling the epidemic of nonalcoholic fatty liver disease demonstrates an exponential increase in burden of disease [J].
Estes, Chris ;
Razavi, Homie ;
Loomba, Rohit ;
Younossi, Zobair ;
Sanyal, Arun J. .
HEPATOLOGY, 2018, 67 (01) :123-133
[10]   Recompensation in cirrhosis: unravelling the evolving natural history of nonalcoholic fatty liver disease [J].
Feng, Gong ;
Valenti, Luca ;
Wong, Vincent Wai-Sun ;
Fouad, Yasser Mahrous ;
Yilmaz, Yusuf ;
Kim, Won ;
Sebastiani, Giada ;
Younossi, Zobair M. ;
Hernandez-Gea, Virginia ;
Zheng, Ming-Hua .
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY, 2024, 21 (01) :46-56